Update lessons from PET imaging part II

• Verfasst von: Hart, Xenia Marlene [VerfasserIn]
• Verfasst von: Spangemacher, Moritz [VerfasserIn]
• Verfasst von: Defert, Julie [VerfasserIn]
• Verfasst von: Uchida, Hiroyuki [VerfasserIn]
• Verfasst von: Gründer, Gerhard [VerfasserIn]
• Titel: Update lessons from PET imaging part II
• Titelzusatz: a systematic critical review on therapeutic plasma concentrations of antidepressants
• Verf.angabe: Xenia M. Hart, Moritz Spangemacher, Julie Defert, Hiroyuki Uchida, Gerhard Gründer
• E-Jahr: 2024
• Jahr: April 2024
• Umfang: 15 S.
• Fussnoten: Gesehen am 23.12.2024
• Titel Quelle: Enthalten in: Therapeutic drug monitoring
• Ort Quelle: Philadelphia, Pa. : Lippincott Williams & Wilkins, 1979
• Jahr Quelle: 2024
• Band/Heft Quelle: 46(2024), 2 vom: Apr., Seite 155-169
• ISSN Quelle: 1536-3694
• DOI: doi:10.1097/FTD.0000000000001142
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1913264793

Abstract

Background: - Compared with antipsychotics, the relationship between antidepressant blood (plasma or serum) concentrations and target engagement is less well-established. - Methods: - We have discussed the literature on the relationship between plasma concentrations of antidepressant drugs and their target occupancy. Antidepressants reviewed in this work are citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, venlafaxine, duloxetine, milnacipran, tricyclic antidepressants (amitriptyline, nortriptyline, and clomipramine), bupropion, tranylcypromine, moclobemide, and vortioxetine. Four electronic databases were systematically searched. - Results: - We included 32 articles published 1996-2022. A strong relationship between serotonin transporter (SERT) occupancy and drug concentration is well established for selective serotonin reuptake inhibitors. Lower limits of recommended therapeutic reference ranges largely corroborate with the findings from positron emission tomography studies (80% SERT occupancy). Only a few novel studies have investigated alternative targets, that is, norepinephrine transporters (NETs), dopamine transporters (DATs), or monoamine oxidase A (MAO-A). For certain classes of drugs, positron emission tomography study data are inconclusive. Low DAT occupancy after bupropion treatment speculates its discussed mechanism of action. For MAO inhibitors, a correlation between drug concentration and MAO-A occupancy could not be established. - Conclusions: - Neuroimaging studies are critical in TDM-guided therapy for certain antidepressants, whereas for bupropion and MAO inhibitors, the available evidence offers no further insight. Evidence for selective serotonin reuptake inhibitors is strong and justifies a titration toward suggested ranges. For SNRIs, duloxetine, and venlafaxine, NETs are sufficiently occupied, well above the SERT efficacy threshold. For these drugs, a titration toward higher concentrations (within the recommended range) should be considered in case of no response at lower concentrations.